Together with its receptor, triggering receptor expressed on myeloid cells 2 (TREM2), TYROBP contributes to the onset and progression of Alzheimer's disease by impacting various cellular processes such as phagocytosis, cytokine production, and inflammation [51]. Here, TYROBP is linked to early-onset autosomal dominant Alzheimer disease.